Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Alnylam's Yvonne Greenstreet sees a massive pay raise as John Maraganore passes the torch
4 years ago
People
Merck opens Virginia plant to support UNICEF deal for HPV vaccines
4 years ago
Manufacturing
Law groups, professors lash out against Thermo Fisher in suit over the 'immortal cells' of Henrietta Lacks
4 years ago
Law
Asthma patients are unfamiliar with biologic brands, but open to try — Phreesia survey
4 years ago
Marketing
Final coverage decision for some Alzheimer's drugs is almost here: What to remember and what to expect
4 years ago
FDA+
Pharma IP in view as new USPTO director Kathi Vidal wins Senate confirmation
4 years ago
Following $1.9B buyout, Sanofi shutters Kadmon's NY site and chops 25 staffers
4 years ago
Catalent wins bidding war to take on UK's VMIC
4 years ago
Manufacturing
Co-founder of Florida pharma indicted after multistate bacterial outbreak at children's hospitals
4 years ago
Manufacturing
Law
Johnson & Johnson drives peripheral artery disease awareness in new ‘Save Legs’ initiative
4 years ago
Marketing
Minnesota judge narrows charges in class action suit against Mylan, pharmacy benefit managers over EpiPen price hikes
4 years ago
Novartis' PI3K drug, already approved in breast cancer, nabs a speedy OK to treat ultra-rare condition
4 years ago
FDA+
As part of broader gene therapy ambitions, Takeda links up again with a small Chicago biotech
4 years ago
Startups
Cell/Gene Tx
Fresh off an $11.5B cardio wager, Merck promises investors a megablockbuster future in a return to the glory days
4 years ago
The bill on Merck's C-suite shakeup includes about $30M for dual CEO pay packages
4 years ago
People
Novartis manufacturing facility in North Carolina gets FDA all-clear to produce, ship gene therapies
4 years ago
Manufacturing
Boehringer Ingelheim boosts R&D commitment, promises up to 15 new product launches by 2025
4 years ago
R&D
Manufacturing
Senators call on HHS to investigate McKinsey's alleged ties with FDA, opioid manufacturers
4 years ago
FDA+
What's going on with Merck's offshore tax practices as tax rate plunges to 11% and Senate Finance Chair Ron Wyden digs in
4 years ago
MarketingRx roundup: Merck reups HPV ads for young adults; Idorsia study confirms little sleep for weary
4 years ago
Marketing
Novo Nordisk trades Rybelsus' animated Covid-launch ads for ‘more relatable’ live action campaign
4 years ago
Marketing
Doug Melton to reunite with his Semma collaborators at Vertex to develop 'curative cell therapies'
4 years ago
People
Cell/Gene Tx
AMR Action Fund looks to tackle antimicrobial resistance with first two investments — but does the money arrive too late?
4 years ago
Financing
Gilead's landmark CAR-T approval leaves Bristol Myers Squibb scrambling for second place
4 years ago
Cell/Gene Tx
Marketing
First page
Previous page
210
211
212
213
214
215
216
Next page
Last page